CHIEF FINANCIAL OFFICER · LeonaBio, Inc. · LeonaBio, Inc. — Restricted Stock Units
Side
M
Value
—
Shares
3,900
Price
—
Executed
Mar 3, 2026
Disclosed
Mar 5, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 3 executedMar 5, 2026 disclosed
LONA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Renninger Robert filed this Form 4 reporting a option exercise of LONA on Mar 3, 2026. It became public on Mar 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF FINANCIAL OFFICER
Renninger Robertcik:0002037968
Issuer
LeonaBio, Inc.cik:0001620463
Revision history · 0
No field has changed since this record was first ingested.
